Portfolio (Quarterly)
Guide ↗
China Universal Asset Management Co., Ltd.
· CIK 0001906594| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 241 | TERN | TERNS PHARMACEUTICALS INC | Healthcare | 14,878.0 | $601K | 0.05% | -461.0 | -3.0% | $40.40 | +31.1% |
| 242 | RGEN | REPLIGEN CORP | Healthcare | 3,600.0 | $590K | 0.04% | -1K | -28.0% | $163.86 | -31.8% |
| 243 | ARQT | ARCUTIS BIOTHERAPEUTICS INC | Healthcare | 19,960.0 | $580K | 0.04% | -1K | -5.0% | $29.04 | -27.7% |
| 244 | TVTX | TRAVERE THERAPEUTICS INC | Healthcare | 15,079.0 | $576K | 0.04% | -546.0 | -3.5% | $38.21 | +13.8% |
| 245 | RDDT | REDDIT INC-CL A | Communication Services | 2,500.0 | $575K | 0.04% | NEW | — | $229.87 | -36.2% |
| 246 | MCD | MCDONALD'S CORP | Consumer Cyclical | 1,861.0 | $569K | 0.04% | -1K | -44.3% | $305.63 | -7.0% |
| 247 | ABT | ABBOTT LABORATORIES | Healthcare | 4,538.0 | $569K | 0.04% | +100.0 | +2.2% | $125.29 | -29.9% |
| 248 | TARS | TARSUS PHARMACEUTICALS INC | Healthcare | 6,917.0 | $566K | 0.04% | -483.0 | -6.5% | $81.88 | -20.9% |
| 249 | XENE | XENON PHARMACEUTICALS INC | Healthcare | 12,592.0 | $564K | 0.04% | -923.0 | -6.8% | $44.82 | +22.0% |
| 250 | CGON | CG ONCOLOGY INC | Healthcare | 13,145.0 | $546K | 0.04% | -220.0 | -1.6% | $41.52 | +55.6% |
| 251 | VCYT | VERACYTE INC | Healthcare | 12,881.0 | $542K | 0.04% | -909.0 | -6.6% | $42.10 | +7.3% |
| 252 | EYPT | EYEPOINT INC | Healthcare | 29,490.0 | $539K | 0.04% | +7K | +33.5% | $18.27 | -30.0% |
| 253 | AXP | AMERICAN EXPRESS CO | Financial Services | 1,451.0 | $537K | 0.04% | NEW | — | $369.95 | -16.3% |
| 254 | DIS | WALT DISNEY CO/THE | Communication Services | 4,688.0 | $537K | 0.04% | +102.0 | +2.2% | $114.44 | -9.5% |
| 255 | VERA | VERA THERAPEUTICS INC | Healthcare | 10,417.0 | $528K | 0.04% | -770.0 | -6.9% | $50.64 | -31.6% |
| 256 | IMCR | IMMUNOCORE HOLDINGS PLC-ADR | Healthcare | 15,109.0 | $524K | 0.04% | +8K | +115.2% | $34.71 | -13.6% |
| 257 | APLS | APELLIS PHARMACEUTICALS INC | Healthcare | 20,617.0 | $518K | 0.04% | -2K | -6.9% | $25.12 | +63.3% |
| 258 | NVO | NOVO-NORDISK A/S-SPONS ADR | Healthcare | 10,000.0 | $509K | 0.04% | NEW | — | $50.88 | -12.8% |
| 259 | IDYA | IDEAYA BIOSCIENCES INC | Healthcare | 14,285.0 | $494K | 0.04% | -1K | -7.0% | $34.57 | -14.6% |
| 260 | ZBIO | ZENAS BIOPHARMA INC | Healthcare | 13,314.0 | $483K | 0.04% | NEW | — | $36.31 | -46.1% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Technology
39.5%
Healthcare
21.2%
Communication Services
12.4%
Financial Services
10.6%
Consumer Cyclical
10.1%
Consumer Defensive
2.7%
Industrials
1.9%
Utilities
0.6%
Basic Materials
0.5%
Energy
0.4%